For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Assembly Biosciences, Inc.

USPTO Granted Patents = 14

% Expired Patents = 35.7

EPO Patents = 6

Forward Citations = 15

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Lee Daniel Arnold (10 out of 10 patents)

Hans Maag (9 out of 10 patents)

Leping Li (8 out of 8 patents)

4. Mark G Bures (8 out of 8 patents)

5. Simon Nicolas Haydar (7 out of 7 patents)

6. William Wilson Turner, Jr (6 out of 16 patents)

7. Samson Francis (5 out of 6 patents)

8. William W Turner (4 out of 17 patents)

9. Roopa Rai (3 out of 3 patents)

10. Lynne Canne Bannen (3 out of 27 patents)

11. Michael Walker (3 out of 3 patents)

12. Adam Zlotnick (2 out of 8 patents)

13. Sreenivasa Reddy Mundla (1 out of 1 patent)

14. Thilo J Heckrodt (1 out of 53 patents)

15. Min Zhong (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12655130 - 5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV (2026-06-16),

2. 12030869 - 5-membered heteroaryl carboxamide compounds for treatment of HBV (2024-07-09),

3. 11814376 - Hepatitis b core protein modulators (2023-11-14),

4. 11560370 - 5-membered heteroaryl carboxamide compounds for treatment of HBV (2023-01-24),

5. 11078170 - Cyclic sulfamide compounds and methods of using same (2021-08-03),

6. 11040965 - Process for making Hepatitis B core protein modulators (2021-06-22),

7. 10987360 - Hepatitis B core protein modulators (2021-04-27),

8. 10968211 - Hepatitis B core protein modulators (2021-04-06),

9. 10947224 - Hepatitis B core protein allosteric modulators (2021-03-16),

10. 10766890 - Hepatitis B core protein modulators (2020-09-08),

11. 10392379 - Hepatitis B core protein modulators (2019-08-27),

12. 10377748 - Hepatitis B core protein modulators (2019-08-13),

13. 10273228 - Hepatitis B viral assembly effectors (2019-04-30),

14. 10183936 - Hepatitis B core protein allosteric modulators (2019-01-22),

Assembly Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for hepatitis B virus (HBV) infection and other serious infectious diseases. Their approach utilizes novel technologies to target and inhibit viral replication, aiming to achieve a functional cure for patients. Assembly Biosciences' dedicated team of scientists and clinicians work tirelessly to advance their pipeline of promising drug candidates, with the ultimate goal of improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

14 Patents

#81 in South San Francisco, CA

#5,305 in California

#22,261 in US

#42,111 in the World

South San Francisco, CA, United States of America

Assembly Biosciences, Inc.

Forward Citations = 15

15 inventors:

Lee Daniel Arnold (10 out of 10 patents)

Hans Maag (9 out of 10 patents)

Leping Li (8 out of 8 patents)

4. Mark G Bures (8 out of 8 patents)

5. Simon Nicolas Haydar (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…